Free Trial
NASDAQ:CRVO

CervoMed (CRVO) Stock Price, News & Analysis

CervoMed logo
$8.90 +0.37 (+4.34%)
Closing price 04:00 PM Eastern
Extended Trading
$9.04 +0.14 (+1.57%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About CervoMed Stock (NASDAQ:CRVO)

Advanced

Key Stats

Today's Range
$8.64
$9.66
50-Day Range
$7.79
$10.69
52-Week Range
$1.80
$16.94
Volume
486,555 shs
Average Volume
97,376 shs
Market Capitalization
$82.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.29
Consensus Rating
Moderate Buy

Company Overview

CervoMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
75th Percentile Overall Score

CRVO MarketRank™: 

CervoMed scored higher than 75% of companies evaluated by MarketBeat, and ranked 278th out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CervoMed has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 6 buy ratings, 1 hold rating, and 2 sell ratings.

  • Upside Potential

    CervoMed has a consensus price target of $19.29, representing about 116.7% upside from its current price of $8.90.

  • Amount of Analyst Coverage

    CervoMed has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about CervoMed's stock forecast and price target.
  • Earnings Growth

    Earnings for CervoMed are expected to grow in the coming year, from ($1.88) to ($1.69) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CervoMed is -3.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CervoMed is -3.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    CervoMed has a P/B Ratio of 1.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about CervoMed's valuation and earnings.
  • Percentage of Shares Shorted

    3.22% of the float of CervoMed has been sold short.
  • Short Interest Ratio / Days to Cover

    CervoMed has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CervoMed has recently decreased by 31.69%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    CervoMed does not currently pay a dividend.

  • Dividend Growth

    CervoMed does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.22% of the float of CervoMed has been sold short.
  • Short Interest Ratio / Days to Cover

    CervoMed has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CervoMed has recently decreased by 31.69%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    CervoMed has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for CervoMed this week, compared to 3 articles on an average week.
  • Search Interest

    6 people have searched for CRVO on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added CervoMed to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CervoMed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    35.40% of the stock of CervoMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 25.15% of the stock of CervoMed is held by institutions.

  • Read more about CervoMed's insider trading history.
Receive CRVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CervoMed and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRVO Stock News Headlines

URGENT: The Market's 3 Red Flags Are Flashing
The warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gold price (signaling fear), and escalating geopolitical risk. A sharp correction might happen tomorrow, and most investors will be caught off guard. Your portfolio is currently exposed.tc pixel
CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer
See More Headlines

CRVO Stock Analysis - Frequently Asked Questions

CervoMed's stock was trading at $2.34 at the start of the year. Since then, CRVO stock has increased by 280.3% and is now trading at $8.90.

CervoMed Inc. (NASDAQ:CRVO) announced its quarterly earnings results on Friday, August, 8th. The company reported ($0.70) EPS for the quarter, missing analysts' consensus estimates of ($0.57) by $0.13. The firm earned $1.76 million during the quarter, compared to analyst estimates of $1.45 million. CervoMed had a negative trailing twelve-month return on equity of 59.15% and a negative net margin of 290.72%.

Shares of CRVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CervoMed investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
8/08/2025
Today
10/08/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CRVO
Previous Symbol
NASDAQ:CRVO
CIK
1053691
Employees
4
Year Founded
N/A

Price Target and Rating

High Price Target
$31.00
Low Price Target
$11.00
Potential Upside/Downside
+117.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.61)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.29 million
Net Margins
-290.72%
Pretax Margin
-290.72%
Return on Equity
-59.15%
Return on Assets
-53.64%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.20
Quick Ratio
8.20

Sales & Book Value

Annual Sales
$9.74 million
Price / Sales
8.41
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.50 per share
Price / Book
1.97

Miscellaneous

Outstanding Shares
9,250,000
Free Float
5,977,000
Market Cap
$81.95 million
Optionable
Not Optionable
Beta
-0.84
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:CRVO) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners